From Proteomics to the Analysis of Single Protein Molecules.

atomic force microscopy limit of detection mass spectrometry molecular counters protein detection proteomics sensitivity in bioanalysis single biomacromolecule

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Sep 2024
Historique:
received: 19 08 2024
revised: 13 09 2024
accepted: 16 09 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Limit of detection (LoD) is a term that is used to characterize the sensitivity of an analytical method. The existing limitation of the sensitivity of analysis using modern mass spectrometry methods has been experimentally shown to be a limiting factor in the application of proteomic technologies in medicine. This article proposes a concept of a new technology that will set a new vector of development in the development of systems for solving problems of medical diagnostics and deals with theoretical and practical aspects of creating a new technology for the detection of single biomacromolecules (in particular, proteins) in biological samples. Such technology should be based on the principle of signal registration similar to that used in a Geiger counter (also known as a Geiger-Müller counter or G-M counter), a device that automatically counts the number of ionizing particles that hit it. This counter is free from probabilistic components; it registers a signal if there is at least one target molecule in the analysis chamber. Predictive medical diagnostics require technology based on methods where sensitivity allows for the detection of single marker molecules in a biological sample volume of 1-10 µL, the smallest volume of biomaterial used in laboratory diagnostics. Creation of a detector with a sensitivity of 10

Identifiants

pubmed: 39408640
pii: ijms251910308
doi: 10.3390/ijms251910308
pii:
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2024-643

Auteurs

Elena A Ponomarenko (EA)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Yuri D Ivanov (YD)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Anastasia A Valueva (AA)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Tatyana O Pleshakova (TO)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Victor G Zgoda (VG)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Nikita E Vavilov (NE)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Ekaterina V Ilgisonis (EV)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Andrey V Lisitsa (AV)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Alexander I Archakov (AI)

Institute of Biomedical Chemistry, 10, Pogodinskaya St., 119121 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH